Pelvic Organ Prolapse Repair Market Size, Share and Global Trend By Product Type (Vaginal Pessary, Vaginal Mesh), By Application (Surgical, Non-surgical), By End User(Hospitals, Speciality Clinics, Nursing Homes, Ambulatory Surgery Centres, Others), and Regional Forecast, 2024-2032

The pelvic organ prolapse is described as a medical condition where the tissues and muscles supporting the pelvic organs become weak or loose. This allows the pelvic organs (the uterus, bladder, small intestine, rectum, part of the vagina) to protrude into or at times out of the vagina. Based on which organ has prolapsed, the pelvic organ prolapse is divided into five types, namely cystocele, enterocele, rectocele, uterine prolapse, and vaginal vault prolapse. Pelvic organ prolapse is more common in older women and rarely happens in women after childbirth. According to The Office on Women's Health, 3% of the U.S. women population was affected by pelvic organ prolapse in 2016. The rising concern for women health has encouraged the launch and production of pelvic organ proplase repair products with reduced risk of complications. Bearing to the complications involved in the use of transvaginal mesh, in 2016, POP Medical Solutions, an Israeli company, has introduced an FDA approved device named new guide, which is a minimally invasive repair system not requiring any kind of dissection. 

The growth in pelvic organ prolapse repair market is being driven by the increase in the incidence of pelvic organ prolapse, an increase in geriatric population and technological advancements in pelvic organ prolapse repair devices. 

To gain extensive insights into the market, Request for Customization

The factors that are expected to impact the growth of the pelvic organ prolapse repair market are the complications involved post-surgery, vaginal bleeding, patient discomfort, and increased risks of infection due to vaginal pessary. In April 2019, the FDA prohibited the selling and distribution of surgical mesh being used for transvaginal repair of pelvic organ prolapse in the U.S., which is expected to negatively impact the sales of vaginal mesh. 

Key Players Covered 

Some of the major companies that are present in the global pelvic organ prolapse repair market are Ethicon USA, LLC., Coloplast Ltd, Boston Scientific Corporation, CooperSurgical Inc., Brad Medical, MedGyn Products Inc., Dr. Arabin GmbH & Co., Personal Medical Corp., Integra LifeSciences, Panpac Medical Corp, and MEDesign Ltd., and other players.  

 SEGMENTATION  

In terms of product type, the vaginal pessary segment is anticipated to witness remarkable growth owing to increased demand for vaginal pessary products. Moreover, the risk of vaginal bleeding associated with vaginal mesh has resulted in more preference for vaginal pessary products. 

Key Insights 

• Prevalence of pelvic organ prolapse disorder for key countries


• Pricing Analysis


• Regulatory scenario for key countries


• New Product Launch


• Recent industry developments such as partnerships, mergers, and acquisitions 

Regional Analysis 

North America is expected to dominate the global pelvic organ prolapse repair market during the forecast period owing to the strategic presence of manufacturers and increase in demand for vaginal pessary rings. The pelvic organ prolapse repair market in Europe is expected to witness growth in the projected period owing to the rising prevalence of pelvic organ prolapse and active government initiatives for women health. Asia Pacific pelvic organ prolapse market is anticipated to register a remarkable growth in the forecast duration due to the rising awareness on womens’ health and rising ageing population.  

Key Industry Developments  

• In August 2018, Invuity Inc. launched PhotonGuide Adapt, a system consisting of flexible illuminator and compatible retractors for vaginal surgery including surgery for pelvic organ prolapse repairs.
• In June 2015, Caldera Medical received FDA clearance for improved version of Vertessa Lite, a vaginal mesh for use in sacrocolpopexy procedures.
• In July 2016, POP Medical Solutions, an Israeli company, received marketing approval from FDA for their device named NeuGuide, which is a minimal invasive repair system not requiring any kind of dissection.